EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeit

Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions

Sunil K Aggarwal, Gregory T Carter, Mark D Sullivan, Craig ZumBrunnen, Richard Morrill, Jonathan D Mayer

Journal of Opioid Management · 29.01.2018 · 5 (3) · 153-168

DOI: 10.5055/jom.2009.0016 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Journal of Opioid Management, online erschienen am 29.01.2018. Verfasst von Sunil K Aggarwal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Phytotherapy. Die Arbeit wurde bisher 144-mal zitiert (Crossref). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis (marijuana) has been used for medicinal purposes for millennia, said to be first noted by the Chinese in c. 2737 BCE. Medicinal cannabis arrived in the United States much later, burdened with a remarkably checkered, yet colorful, history. Despite early robust use, after the advent of opioids and aspirin, medicinal cannabis use faded. Cannabis was criminalized in the United States in 1937, against the advice of the American Medical Association submitted on record to Congress. The past few decades have seen renewed interest in medicinal cannabis, with the National Institutes of Health, the Institute of Medicine, and the American College of Physicians, all issuing statements of support for further research and development. The recently discovered endocannabinoid system has greatly increased our understanding of the actions of exogenous cannabis. Endocannabinoids appear to control pain, muscle tone, mood state, appetite, and inflammation, among other effects. Cannabis contains more than 100 different cannabinoids and has the capacity for analgesia through neuromodulation in ascending and descending pain pathways, neuroprotection, and anti-inflammatory mechanisms. This article reviews the current and emerging research on the physiological mechanisms of cannabinoids and their applications in managing chronic pain, muscle spasticity, cachexia, and other debilitating problems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytotherapyCachexiaCannabinoid Receptor ModulatorsCannabinoidsCannabisCrimeHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHistory, AncientHumansMuscle SpasticityPainUnited States

Substanzen

Cannabinoid Receptor ModulatorsCannabinoids

Autor:innen und Institutionen

  • Medical Scientist Training Program, University of Washington, Seattle, WA, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Aggarwal, S. K., Carter, G. T., Sullivan, M. D., ZumBrunnen, C., Morrill, R., & Mayer, J. D. (2018). Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions. Journal of Opioid Management, 5(3), 153-168. https://doi.org/10.5055/jom.2009.0016

Vancouver

Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD. Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions. Journal of Opioid Management. 2018;5(3):153-168. doi:10.5055/jom.2009.0016

BibTeX
@article{Aggarwal2018,
  author = {Aggarwal, Sunil K and Carter, Gregory T and Sullivan, Mark D and ZumBrunnen, Craig and Morrill, Richard and Mayer, Jonathan D},
  title = {Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions},
  journal = {Journal of Opioid Management},
  year = {2018},
  volume = {5},
  number = {3},
  pages = {153--168},
  doi = {10.5055/jom.2009.0016}
}
Kostenlos starten →